NVST · Envista Holdings Corp

$28.07 -0.01 (-0.04%) At close · Aug 14

Market Cap

$4.51B

160.62M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Keel	President & CEO	$1,100,000	—	$5,440,152	$1,360,045	$2,486,550	$172,820	$10,559,567
Eric Hammes	Chief Financial Officer	$592,308	—	$975,153	$325,009	$739,800	$13,700	$2,645,970
Mark Nance	SVP and General Counsel	$559,615	—	$1,125,143	$375,017	$551,425	$33,986	$2,645,186
Veronica Acurio	President, Orthodontics	$550,000	—	$637,674	$212,513	$720,720	$52,197	$2,173,104
Robert Befidi	President, Diagnostics	$567,308	—	$637,674	$212,513	$470,925	$47,847	$1,936,267

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Paul Keel	President & CEO, from May 1, 2024	$1,100,000	$281,466	$10,700,076	$10,700,093	$1,086,144	$368,578	$24,236,357
Eric Hammes	Chief Financial Officer, from August 1, 2024	$575,000	$1,020,000	$1,200,073	—	$168,934	$238,913	$3,202,920
Mark Nance	SVP and General Counsel	$525,000	—	$1,062,766	$1,052,374	$424,463	$39,275	$3,103,878
Robert Befidi	President, Diagnostics	$550,000	—	$637,684	$777,905	$334,950	$13,800	$2,314,339
Stephen Keller	Principal Financial Officer, until August 1, 2024	$460,000	—	$750,169	$150,008	—	$37,016	$1,397,193

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO, until May 1, 2024	$1,100,000	—	$4,160,158	$1,040,020	—	$759,147	$7,059,325
Howard Yu	Senior Vice President and CFO, until September 22, 2023	$550,000	—	$1,181,452	$393,853	—	$113,522	$2,238,827
Eric Conley	President, Orthodontics	$500,000	—	$1,175,389	$175,010	$208,250	$58,612	$2,117,261
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions, until June 30, 2023	$525,000	—	$637,770	$212,626	—	$473,796	$1,849,192
Patrik Eriksson	SVP and President of Nobel Biocare, until December 31, 2023	$550,000	—	$637,770	$212,626	$103,950	$97,260	$1,601,606
Mark Nance	SVP and General Counsel	$525,000	—	$712,534	$237,650	—	$67,956	$1,543,140
Stephen Keller	Principal Financial Officer, until August 1, 2024	$410,000	—	$125,078	$125,121	—	$43,728	$703,927

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO, until May 1, 2024	$1,100,000	—	$4,080,220	$1,020,101	$725,313	$1,598,098	$8,523,732
Howard Yu	Senior Vice President and CFO, until September 22, 2023	$525,000	—	$1,125,063	$375,058	$217,547	$99,595	$2,342,263
Patrik Eriksson	SVP and President of Nobel Biocare, until December 31, 2023	$550,000	—	$637,582	$212,579	$203,088	$81,519	$1,684,768
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions, until June 30, 2023	$525,000	—	$637,582	$212,579	$229,688	$59,315	$1,664,164
Mark Nance	SVP and General Counsel	$525,000	—	$675,295	$225,104	$174,038	$54,598	$1,654,035

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO	$1,100,000	—	$2,350,004	$2,350,018	$2,268,750	$1,130,976	$9,199,748
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions, until June 30, 2023	$475,000	—	$425,118	$2,425,059	$497,503	$32,628	$3,855,308
Howard Yu	Senior Vice President and CFO, until September 22, 2023	$525,000	—	$500,049	$500,086	$639,844	$62,751	$2,227,730
Patrik Eriksson	SVP and President of Nobel Biocare, until December 31, 2023	$550,000	—	$425,118	$425,032	$532,263	$86,598	$2,019,011
Mark Nance	SVP and General Counsel	$525,000	—	$350,186	$350,080	$519,750	$50,486	$1,795,502

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO	$1,007,981	—	$2,250,115	$2,250,042	$1,375,000	$487,756	$7,370,894
Howard Yu	Senior Vice President and CFO	$495,048	—	$500,055	$500,017	$374,063	$64,469	$1,933,652
Patrik Eriksson	SVP and President of Nobel Biocare	$519,327	—	$425,060	$425,069	$351,313	$76,146	$1,796,915
Mark Nance	SVP and General Counsel	$495,721	—	$300,113	$300,010	$315,000	$17,881	$1,428,725
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions	$380,913	—	$337,610	$337,557	$345,732	$1,462	$1,403,274

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO	$784,518	—	$2,262,245	$3,278,368	$503,140	$754,241	$7,582,512
Hans Geiselhöringer	Senior Vice President	$785,449	—	$609,558	$684,853	$148,622	$145,721	$2,374,203
Patrik Eriksson	SVP and President of Nobel Biocare	$486,677	—	$684,468	$714,090	$384,993	$61,117	$2,331,345
Curt Bludworth	Senior Vice President & CHRO	$450,000	$100,000	$585,322	$561,595	$171,720	$163,937	$2,032,574
Howard Yu	Senior Vice President and CFO	$407,129	$85,000	$657,832	$690,462	$146,378	$16,800	$2,003,601

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO	$608,615	—	$3,246,926	$2,160,419	$403,004	$180,193	$6,599,157
Hans Geiselhöringer	Senior Vice President	$772,388	—	$498,678	$341,976	$379,231	$145,230	$2,137,503
Howard Yu	Senior Vice President and CFO	$330,552	—	$217,302	$154,829	$159,558	$1,059,498	$1,921,739
Curt Bludworth	Senior Vice President & CHRO	$424,728	$270,267	$398,942	$273,625	—	$86,262	$1,453,824
Patrik Eriksson	SVP and President of Nobel Biocare	$444,206	—	$448,810	$307,690	$171,423	$80,872	$1,453,001

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Amir Aghdaei	President & CEO	$573,481	—	$778,441	$459,545	$410,550	$1,288,281	$3,510,298

Executive changes

Person	Role	Change	Effective	Filed
Coree Thomas	Vice President and Chief Accounting Officer	Appointed	2026-08-06	2026-06-03
Faez Kaabi	Chief Accounting Officer and principal accounting officer	Retired	2026-08-06	2026-06-03
Barbara B. Hulit	Board of Directors	Resigned	2025-09-26	2025-09-17
J. Andrew Pierce	Board of Directors	Appointed	2025-07-14	2025-07-16
Eric Hammes	Senior Vice President and Chief Financial Officer	Appointed	2024-08-08	2024-07-15
Eric Conley	SVP and President, Orthodontics	Resigned	2024-06-03	2024-05-30
Paul Keel	Board of Directors	Appointed	2024-05-01	2024-04-15
Paul Keel	President and Chief Executive Officer	Appointed	2024-05-01	2024-04-15
Andrew Chen	Chief Information Officer	Appointed	—	2023-12-14
Suraj Satpathy	Chief Human Resources Officer	Appointed	—	2023-12-14
Robert Befidi	President, Diagnostics	Appointed	—	2023-12-14
Patrik Eriksson	SVP and President, Nobel Biocare	Terminated	2023-12-31	2023-12-14
Faez Kaabi	Vice President and Chief Accounting Officer	Appointed	2023-09-22	2023-07-26
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions	Terminated	2023-06-30	2023-06-30
Jean-Claude Kyrillos	SVP and President, Diagnostics and Digital Solutions	Terminated	2023-06-30	2023-04-14
Howard H. Yu	principal accounting officer	Appointed	2022-04-22	2022-03-30
Kari-Lyn Moore	Chief Accounting Officer and principal accounting officer	Resigned	2022-04-22	2022-03-30

Key facts CIK 1757073 CUSIP 29415F104 13F (30d) 357 filings 347 filers Visit website Investor relations